Glycopyrronium bromide/Formoterol

Abbreviation
GFF
Disease(s)
Chronic Obstructive Pulmonary Disease (COPD)
Background
.pdf
Patent oppositions filed in
Argentina

Glycopyrronium bromide/formoterol is a fixed-dose combination of the long-acting muscarinic antagonist glycopyrronium bromide and the long-acting β2-agonist formoterol fumarate used as inhalers for treatment of COPD patients.

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Argentina25-11-2016CILFAPre-GrantUnder ExaminationFormulationsAR098983A1View/Comment
Argentina25-11-2016CILFAPre-GrantUnder ExaminationFormulationsAR098982A1View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top